Recruiting Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer NCT05941520 Conditions Adenocarcinoma, Breast Atypical Hyperplasia, Breast Carcinoma, +15 more Locations City of Hope Comprehensive Cancer Center — Duarte, California, United States Northwestern University — Chicago, Illinois, United States University of Kansas Cancer Center — Kansas City, Kansas, United States Ohio State University Comprehensive Cancer Center — Columbus, Ohio, United States View Trial Details
Recruiting Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction NCT06195306 Conditions Adenocarcinoma, Breast Atypical Hyperplasia, Breast Carcinoma, +15 more Locations University of Kansas Cancer Center — Kansas City, Kansas, United States University of Michigan Rogel Cancer Center — Ann Arbor, Michigan, United States Ohio State University Comprehensive Cancer Center — Columbus, Ohio, United States View Trial Details
